In mice, blocking heart-to-brain signals improved healing after a heart attack, hinting at new targets for cardiac therapy.

The brain and vagus nerve play a key role in exacerbating tissue damage after a heart attack, but there are ways to block it.

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Maintaining a stable heartbeat is critical for survival. Your heart must constantly adapt its output to meet changing demands ...

Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...

University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse ...

Scientists have identified a key reason why more than half of people with chronic kidney disease eventually die from heart-related conditions. New evidence shows that damaged kidneys release a ...

Heart failure sounds alarming—and rightfully so. Yet approximately 6.5 million Americans currently live with this condition, many with the specific variant called systolic heart failure, and a ...

Heart attack symptoms in women can differ from the classic warning signs portrayed in men. Women may notice symptoms such as ...

Good news: Treats are on the table!

Ifetroban significantly improved LVEF in DMD patients, showing a 5.4% improvement compared with propensity-matched natural history controls, with high-dose treatment yielding the most benefit. The ...